Outcomes of bleb needling with 5-fluorouracil post trabeculectomy among glaucoma patients in Kelantan.
Article Sidebar
Main Article Content
Abstract
Purpose: To evaluate the outcomes of bleb needling with 5-FU post-trabeculectomy among glaucoma patients in Kelantan.
Methods: A retrospective analysis of glaucoma patients undergoing bleb needling with 5-FU from January 2020 to December 2023 was conducted at Hospital Raja Perempuan Zainab II with at least one year of follow-up post-needling. Outcomes were assessed based on intraocular pressure (IOP), use of anti-glaucoma medication (AGM), complications, and overall success rates. Statistical comparisons were made using Fisher’s exact test and Mantel-Haenszel chi-square.
Results: Twenty-four patients completed the one-year follow-up, all of whom were predominantly Malay (100%) with a median age of 54 years. Primary open-angle glaucoma accounted for 45.8% of cases. The median IOP was significantly reduced from 22 mmHg pre-needling to 12 mmHg at 12 months post-needling. AGM use decreased substantially, with nearly two-thirds requiring no AGM after one year. Complete and qualified success rates were 62.5% and 20.8%, respectively. Subconjunctival haemorrhage (87.5%) was the most common complication, while hypotony occurred more frequently in failed cases. Success was significantly associated with a reduction in AGM use (p = 0.018).
Conclusion: Bleb needling with 5-FU demonstrates high efficacy and acceptable safety in managing failing trabeculectomy blebs among glaucoma patients in Kelantan. Sustained IOP reduction and reduced AGM use highlight its potential in resource-constrained settings. Prior AGM usage and patient age might influence surgical success. Vigilance regarding complications like hypotony is essential for optimizing outcomes. Larger, prospective studies are recommended to validate predictive factors of success.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Michels TC, Ivan O. Glaucoma: diagnosis and management. Am Fam Physician. 2023;107(3):253-262.
Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmol. 2014;121(11):2081-2090.
Liu W, Wang J, Zhang M, Tao Y, Sun Y. Comparison of subconjunctival mitomycin C and 5-fluorouracil injection for needle revision of early failed trabeculectomy blebs. J Ophthalmol. 2016;2016(1):3762674.
Tsai AS, Boey PY, Htoon HM, Wong TT. Bleb needling outcomes for failed trabeculectomy blebs in Asian eyes: a 2-year follow up. Int J Ophthalmol. 2015;8(4):748.
Mitra A, Ramakrishnan R, Kader MA. Long term outcome of 5-Fluorouracil (5-FU) augmented bleb needling revision of failed and failing filtration blebs. Asian J Ophthalmol. 2016;14(4).
Chen X, Suo L, Hong Y, Zhang C. Safety and efficacy of bleb needling with antimetabolite after trabeculectomy failure in glaucoma patients: a systemic review and metaanalysis. J Ophthalmol. 2020;2020(1):4310258.
Reddy SC, Tajunisah I, Low KP, Karmila AB. Prevalence of eye diseases and visual impairment in urban population–a study from University of Malaya Medical Centre. Malays Fam Physician. 2008;3(1):25.
Foo CY, Lim KK, Sivasampu S, Dahian KB, Goh PP. Improving the effectiveness of service delivery in the public healthcare sector: the case of ophthalmology services in Malaysia. BMC Health Serv Res. 2015;15(1):349.
Chew FL, Salowi MA, Mustari Z, Husni MA, Hussein E, Adnan TH, et al. Estimates of visual impairment and its causes from the National Eye Survey in Malaysia (NESII). PloS One. 2018;13(6):e0198799.
Lee RH, Lee RK, Pasquale LR. Burden of trabeculectomy and glaucoma drainage implantation after laser trabeculoplasty: a two-year follow-up study. Ophthalmol Glaucoma. 2022;5(1):58-66.
Rao A, Cruz RD. Trabeculectomy: does it have a future? Cureus. 2022;14(8).
Arifin WN. Sample size calculator [Internet]. 2025 [cited May 2, 2025]. Available from: https://wnarifin.github.io/ssc/ss1prop.html.
Prutthipongsit A. Outcome of needle revisions with subconjunctival 5-fluorouracil in filtration blebs. EyeSEA. 2019;14(1):50-57.
R Core Team. R: A language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2025 [cited May 2, 2025]. Available from: https://www.R-project.org.
Department of Statistics Malaysia. Key findings from the Population and Housing Census of Malaysia, 2020 [Internet]. 2022 [cited May 2, 2025]. Available from: https://www.dosm.gov.my/.
Ye X, She X, Shen L. Association of sex with the global burden of glaucoma: an analysis from the global burden of disease study 2017. Acta ophthalmol. 2020;98(5):e593-e598.
Shan S, Wu J, Cao J, Feng Y, Zhou J, Luo Z, et al. Global incidence and risk factors for glaucoma: A systematic review and meta-analysis of prospective studies. J Glob Health. 2024;14:04252.
Demirok G, Kaderli A, Kaderli ST, Üney G, Yakin M, Ekşioğlu Ü. Factors affecting the early and mid-term success of needling for early failure of filtering bleb. Indian J Ophthalmol. 2021;69(2):296-300.
Zhang Y, Zhu S, Xu X, Zuo L. In Vitro Study of Combined Application of Bevacizumab and 5-Fluorouracil or Bevacizumab and Mitomycin C to Inhibit Scar Formation in Glaucoma Filtration Surgery. J Ophthalmol. 2019;2019(1):7419571.
Ang BC, Lim SY, Betzler BK, Wong HJ, Stewart MW, Dorairaj S. Recent advancements in glaucoma surgery-a review. Bioeng. 2023;10(9):1096.
Das N, Manju M, Chandran P, Dhavalikar M, Sivakumar P, Vimalanathan M, et al. Outcomes of bleb needling in primary glaucoma: A prospective interventional study in a South Indian population. Indian J Ophthalmol. 2022;70(12):4201-4205.
Satpute K, Bukke AN, Verma S, Dada T. Conjunctival advancement for management of hypotony maculopathy after trabeculectomy. BMJ Case Rep. 2022;15: e251718.
Purang AK, Pegu J, Dubey S. Role of Bleb Needling in Rescuing Failing Blebs-A Review. Delhi J Ophthalmol. 2018;29(2):17-21.
Iraha S, Takihara Y, Urahashi Y, Watanabe T, Nakamura K, Urahashi M, et al. Factors associated with the surgical outcomes of Baerveldt glaucoma implant for open angle glaucoma, an age-related eye disease. Sci Rep. 2022;12(1):1359.
